Zika vaccine

Promising Zika vaccine moves to next stage

Dr. Anthony Fauci, director of the National Institute of Allergy and Infectious Diseases, part of the National Institutes of Health, said Friday that the DNA vaccine candidate developed by scientists at NIAID's Vaccine Research Center has been a success in animal trials and in the first human trial of the vaccine.

It has been such a success that the agency has moved into the next stage of testing, on track with its projected timeline.

Zika vaccines show early promise

Scientists found all three offered protection in tests on rhesus monkeys.

Zika has been deemed a public health emergency, because it can cause serious birth defects.

Teams around the world are working to design a vaccine that can be given to people, but it is likely to be years before any is ready for widespread use.

More than 60 countries and territories now have continuing transmission of Zika, which is carried by mosquitoes.

Indian biotech company claims to have vaccine in development, help needed for faster roll-out


An Indian biotech company claims to have developed a vaccine for the Zika virus, but says it will not be available for a few years without help from the government and the World Health Organisation (WHO).